Biotech

All Articles

Sanofi's $80M bank on Fulcrum dystrophy drug ends in period 3 fail

.Only 4 months after Sanofi wager $80 thousand in upfront money on Fulcrum Rehabs' losmapimod, the c...

Oncternal equity drains 60% amid layoffs, test firings

.Cancer business Oncternal Rehabs is actually folding all its medical trials and laying off personne...

Roche is carrying out hopes that its injectable weight problems prospect can ultimately show 25% weight loss in late-stage trial

.Roche is keeping out hopes that its injectable weight problems prospect might ultimately show 25% f...

Novo Nordisk hails 'outstanding' effective weight loss lead for dual-acting oral drug in early trial

.Novo Nordisk has lifted the lid on a stage 1 trial of its own oral amylin and also GLP-1 receptor c...

AbbVie sues BeiGene over blood stream cancer cells medicine trade secrets

.Merely a few quick full weeks after succeeding an FDA Fast Track tag for its investigational BTK de...

Lilly delivers one-two strike along with 2nd tranche of favorable information on every week the hormone insulin prospect

.Not long after a positive information decrease for Eli Lilly's efsitora alfa, the Indianapolis-base...

BridgeBio cuts genetics treatment budget as scientific data dissatisfy

.BridgeBio Pharma is lowering its genetics therapy budget plan and also drawing back from the method...

GSK submits HSV injection really hopes after stage 2 stop working, delivering race to Moderna, BioNTech

.GSK's attempt to establish the 1st injection for herpes simplex virus (HSV) has actually finished i...

GSK's long-acting asthma medication cut in half assaults in stage 3

.GSK's long-acting bronchial asthma treatment has been actually shown to cut in half the lot of assa...

AstraZeneca, Daiichi unload Dato-DXd's general survival fall short

.AstraZeneca and also Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has stopped work...